trimethylamine has been researched along with Cirrhosis, Liver in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Liver fibrosis is one main histological characteristic of nonalcoholic steatohepatitis (NASH), a disease paralleling a worldwide surge in metabolic syndromes with no approved therapies." | 1.72 | Trimethylamine-N-oxide (TMAO) mediates the crosstalk between the gut microbiota and hepatic vascular niche to alleviate liver fibrosis in nonalcoholic steatohepatitis. ( Ding, BS; Mo, C; Xiao, C; Zhang, J; Zhou, D, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, D | 1 |
| Zhang, J | 1 |
| Xiao, C | 1 |
| Mo, C | 1 |
| Ding, BS | 1 |
| Ryu, SD | 1 |
| Yi, HG | 1 |
| Cha, YN | 1 |
| Kang, JH | 1 |
| Kang, JS | 1 |
| Jeon, YC | 1 |
| Park, HK | 1 |
| Yu, TM | 1 |
| Lee, JN | 1 |
| Park, CS | 1 |
| Marks, R | 1 |
| Dudley, F | 1 |
| Wan, A | 1 |
3 other studies available for trimethylamine and Cirrhosis, Liver
| Article | Year |
|---|---|
Trimethylamine-N-oxide (TMAO) mediates the crosstalk between the gut microbiota and hepatic vascular niche to alleviate liver fibrosis in nonalcoholic steatohepatitis.
Topics: Animals; Disease Models, Animal; Gastrointestinal Microbiome; Liver Cirrhosis; Methylamines; Mice; N | 2022 |
Flavin-containing monooxygenase activity can be inhibited by nitric oxide-mediated S-nitrosylation.
Topics: Adult; Ascorbic Acid; Carcinoma, Hepatocellular; Dithiothreitol; Enzyme Inhibitors; Hepatitis B, Chr | 2004 |
Trimethylamine metabolism in liver disease.
Topics: Choline; Chronic Disease; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Methylamines | 1978 |